Core Viewpoint - Organon announced the resignation of CEO Kevin Ali, who will be replaced by Joseph Morrissey on an interim basis following an internal investigation into wholesaler sales practices for its Nexplano product [1] Group 1 - The internal investigation was initiated to examine wholesaler sales practices related to the company's Nexplano product [1] - Joseph Morrissey will serve as the interim CEO while the company navigates this transition [1] - The leadership change comes amid scrutiny of sales practices, indicating potential challenges for the company [1]